Joshua Gustafson

4PUBLICATIONS

52CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 18, 2026

The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Sep 10, 2024

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Mar 05, 2024

Differential protein-protein interactions underlie signaling mediated by the TCR and a 4-1BB domain-containing CAR.

Samuel A Ritmeester-Loy, Isabella H Draper, Eric C Bueter

|Oct 19, 2022

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

Pageof 1

Frequent Collaborators

Ashley L Wilson

Julie R Park

Wenjun Huang

Christopher Brown

Rebecca A Gardner

Navin Pinto

Rimas Orentas

Catherine M Albert

Michael C Jensen

Kristy Seidel

Frequent Collaborators

Ashley L Wilson

Julie R Park

Wenjun Huang

Christopher Brown